Skip to main content
. 2018 Mar 14;17(5):7191–7201. doi: 10.3892/mmr.2018.8748

Figure 2.

Figure 2.

APN reduces the levels of IL-6 and TNF-α, in addition to MPO activity, following ischemia/reperfusion. The results are expressed as the mean ± standard deviation. *P<0.05 vs. NS group, #P<0.05 vs. NIR group, ^P<0.05 vs. NIRA group, $P<0.05 vs. DS group and &P<0.05 vs. DIR group. NIR, I/R, in which the lung was subjected to 90 min of ischemia and 4 h of reperfusion; NIRA, I/R + gAPN, in which 10 µg gAPN was injected 10 min prior to reperfusion; NS, Sham group, in which the left lung hilum was not clamped; DIR, diabetic I/R group, in which the lung was subjected to 90 min of ischemia and 4 h of reperfusion; DIRA, diabetic I/R + gAPN group, in which 10 µg gAPN was injected 10 min prior reperfusion; DS, diabetic sham group, in which the left lung hilum was not clamped; MPO, myeloperoxidase; TNF-α, tumor necrosis factor-α; gAPN, adiponectin globular domain; IL-6, interleukin-6; I/R, ischemia/reperfusion.